SCHEMBL42521

SCHEMBL42521

CCCCOC([NH])=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL42379 0.92
SCHEMBL420528 0.91 ALDH1A1 (0.52)
SCHEMBL8500333 0.90 NAAA (0.61)
SCHEMBL76042 0.90 NAAA (0.61)
SCHEMBL104549 0.90 NAAA (0.61)
SCHEMBL55807 0.90 NAAA (0.61)
SCHEMBL1170322 0.90 NAAA (0.61)
SCHEMBL2046899 0.90 NAAA (0.61)
SCHEMBL4620117 0.90 NAAA (0.61)
SCHEMBL8496408 0.90 NAAA (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3590 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117986215-A 2-Phenyl-4-acyl benzofurans, preparation and application thereof 中国医学科学院药物研究所 2024-05-07 CN claimed
US-20230399320-A1 NOVEL CAPSID ASSEMBLY INHIBITOR Pelemed Co., Ltd. (UA) 2023-12-14 US claimed
EP-4242203-A1 NOVEL CAPSID ASSEMBLY INHIBITOR Pelemed Co., Ltd. (KR) 2023-09-13 EP claimed
US-20230201144-A1 BIARYLSULFONAMIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE FOR TREATING FIBROTIC LUNG DISEASE NOVOMEDIX, LLC (US) 2023-06-29 US claimed
WO-2023090829-A1 LOW-MOLECULAR-WEIGHT COMPOUND FOR REGULATING MLL1-WDR5 INTERACTION AND USE THEREOF 엘젠테라퓨틱스 주식회사 2023-05-25 WO claimed
EP-4157249-A1 BIARYLSULFONAMIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE FOR TREATING FIBROTIC LUNG DISEASE Novomedix, LLC (US) 2023-04-05 EP claimed
WO-2021243319-A1 BIARYLSULFONAMIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE FOR TREATING FIBROTIC LUNG DISEASE NOVOMEDIX, LLC (US) 2021-12-02 WO claimed
US-20210347780-A1 CDPK1 INHIBITORS, COMPOSITIONS, AND METHODS RELATED THERETO Vyera Pharmaceuticals, LLC 2021-11-11 US claimed
EP-3706899-A1 BISPHENOL HYPERSORBENTS FOR ENHANCED DETECTION OF, OR PROTECTION FROM, HAZARDOUS CHEMICALS The Government Of The United States Of America As The Secretary of The Navy (US) 2020-09-16 EP claimed
US-20190134601-A1 BISPHENOL HYPERSORBENTS FOR ENHANCED DETECTION OF, OR PROTECTION FROM, HAZARDOUS CHEMICALS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2019-05-09 US claimed
EP-0582810-A1 Novel 7-(substituted)-8-(substituted)-9-(substituted amino)-6-demethyl-6-deoxyetracyclines as antibiotic agents AMERICAN CYANAMID COMPANY (US) 1994-02-16 EP claimed
EP-0346847-A2 Amino acid derivatives F. HOFFMANN-LA ROCHE AG (CH) 1989-12-20 EP claimed
EP-0331609-A2 Angiotensin converting enzyme inhibitors having psychotropic effects HOECHST AKTIENGESELLSCHAFT (DE) 1989-09-06 EP claimed
US-4863945-A CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1989-09-05 US claimed
EP-0302826-A2 Process for the preparation of unsaturated amino acid compounds CIBA-GEIGY AG (CH) 1989-02-08 EP claimed
US-4767757-A Acyloxythiophene-carboxamide fungicides, compositions and use BAYER AKTIENGESELLSCHAFT (DE) 1988-08-30 US claimed
EP-0241735-A2 Acyloxythiophene carbon amide BAYER AG (DE) 1987-10-21 EP claimed
EP-0125684-B1 2-ALKYLTHIO-1-AMINOALKYL-2-PYRROLINE-3-CARBONITRILES, PROCESS FOR THEIR PREPARATION AND MEDICINES WITH ANTI-THROMBOTIC EFFECTS CONTAINING THEM GÖDECKE AKTIENGESELLSCHAFT (DE) 1987-07-08 EP claimed
EP-0214570-A2 N-alkylated tripeptides, process for their preparation, medicaments containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1987-03-18 EP claimed
US-4119777-A BY OXIDATION OF A THIOAMIDE DERIVATIVE FUJI PHOTO FILM CO., LTD. (JP) 1978-10-10 US claimed